1. Manhapra A, Stefanovics E, Rosenheck R. Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what? Subst Abus. 2019:1-11.
2. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder; Mancher M, Leshner AI, eds. Medications for Opioid Use Disorder Save Lives. Washington (DC): National Academies Press (US); 2019. https://doi.org/10.17226/25310. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538936/. Accessed Jun 19, 2020.
3. President Donald J. Trump is Combatting the Opioid Crisis. The Whitehouse https://www.whitehouse.gov/briefings-statements/president-donald-j-trump-combatting-opioid-crisis/. Published 2018. Accessed Jun 19, 2020.
4. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder. Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. Available from: https://www.hsrd.research.va.gov/publications/esp/reports.cfm. Accessed 19 Jun 2020
5. Berkman ND, Lohr KN, Ansari M, et al. Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD; 2013.